Senescence in liver cells is found by CSHL scientists to help limit acute tis... (lesions may provide effective treatment ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> NEWS

Senescence in liver cells is found by CSHL scientists to help limit acute tissue damage

Date:8/21/2008

lesions may provide effective treatment for patients with acute liver damage, particularly in its early stages following short-term exposure to toxic agents.

'/>"/>

Contact: Peter Tarr
tarr123@gmail.com
516-367-8455
Cold Spring Harbor Laboratory
Source:Eurekalert

0

GOOD

Page: 1 2 3 4
Related biology news :

1. Carnegie Mellon scientists develop nanogels that enable controlled delivery of carbohydrate drugs
2. Clearance of hepatitis C viral infection after liver transplantation
3. Targeting nerve growth factor may cure liver cancer
4. Mountain pine beetle: Canadas new government delivers
5. Using green chemistry to deliver cutting-edge drugs
6. Mixing large doses of both acetaminophen painkiller and caffeine may increase risk of liver damage
7. Jumping genes could make for safer gene delivery system
8. Nanoengineers mine tiny diamonds for drug delivery
9. Computer solution to delivery problem
10. Genetic ancestral testing cannot deliver on its promise, study warns
11. Carnegie Mellon researchers to develop new drug delivery system

Post Your Comments:

Breaking Biology News(10 mins):The Academy of Natural Sciences and Temple Press revive rare natural history work in new book 2 Einstein receives high-risk/high-reward cancer research funding 2 Einstein receives high-risk/high-reward cancer research funding 3 Munich lab demonstrates diesel truck engine with barely measurable emissions 2 Munich lab demonstrates diesel truck engine with barely measurable emissions 3 Talyst and RXinnovate Partner on Pharmacy Automation Implementation 5138 1 Talyst and RXinnovate Partner on Pharmacy Automation Implementation 5138 2 Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 1 Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 2 Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 3 Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting 5136 4 Premier Research Appoints Troy W McCall Ph D as Chief Executive Officer 5134 1 Premier Research Appoints Troy W McCall Ph D as Chief Executive Officer 5134 2

[0] The Academy of Natural Sciences and Temple Press revive rare natural history work in new book [0] Einstein receives high-risk/high-reward cancer research funding [0] Munich lab demonstrates diesel truck engine with barely measurable emissions

Other Biology News:Cougar predation key to ecosystem health 2 Cougar predation key to ecosystem health 3 Cougar predation key to ecosystem health 4 Viral marker of human migration suspect 2 Trotting with emus to walk with dinosaurs 2 Trotting with emus to walk with dinosaurs 3

Cougar predation key to ecosystem health Viral marker of human migration suspect Trotting with emus to walk with dinosaurs

Breaking Biology Technology:AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 2 AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 3 Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 2 Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 3 WuXi PharmaTech Selects Labcyte POD(TM) 810 Platform for High-Throughput Screening 2 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5 RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6

[0] AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia [0] Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. [0] WuXi PharmaTech Selects Labcyte POD(TM) 810 Platform for High-Throughput Screening [0] RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE)

Other Biology Technology:Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week 2 Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week 3 Cord Blood America Says Debt Reduced $4.194 Million in 2009 2 Microbia, Inc. Names Alex Chu as Vice President of Process Development 2

Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week Cord Blood America Says Debt Reduced $4.194 Million in 2009 Microbia, Inc. Names Alex Chu as Vice President of Process Development

Biology Products:

Anti-Mouse Laminin-1 Monoclonal Antibody, Unconjugated, Clone AL-3 from R&D Systems Rabbit Anti-Rat Potassium Channel EAG-1 Antibody, Unconjugated from CHEMICON Goat Anti-IEX-1 S / L Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.Goat Anti-WIF-1 (N-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.